Loading clinical trials...
Loading clinical trials...
The Amplitude Change of the Auditory Evoked N1 Component as a Predictor of Response to Escitalopram Treatment in Patients With Generalized Anxiety Disorder
Conditions
Interventions
escitalopram
Locations
1
South Korea
Psychiatry department, Inje Univ. Ilsanpaik Hospital
Goyang, Kyunggi, South Korea
Start Date
December 1, 2007
Primary Completion Date
April 1, 2010
Completion Date
May 1, 2010
Last Updated
June 30, 2010
NCT07429578
NCT06661460
NCT06846320
NCT07330648
NCT07119515
NCT05393518
Lead Sponsor
Inje University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions